Travere Therapeutics, Inc. (TVTX)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 07, 2025

$21.75

P/E Ratio

N/A

Market Cap

$1.89B

Description
Add to research

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Metrics
Add to research

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerTVTX
  • Price$21.75-0.50%

Trading Information

  • Market cap$1.89B
  • Float98.49%
  • Average Daily Volume (1m)1,409,628
  • Average Daily Volume (3m)1,286,212
  • EPS-$4.56

Company

  • Revenue$203.45M
  • Rev growth (1yr)69.56%
  • Net income-$54.75M
  • Gross margin79.55%
  • EBITDA margin-71.21%
  • EBITDA-$44.79M
  • EV$1.21B
  • EV/Revenue5.96
  • P/EN/A
  • P/S8.32
  • P/BN/A
  • Debt/EquityN/A
Documents
Add to research